Durante los seis primeros meses del año, Natac ha ingresado 19,6 millones de euros, lo que supone un incremento del 70% con respecto al mismo periodo del año pasado, mientras que su EBITDA ha supera...
Bio & Tech Smart Capital FCRE, fondo de capital riesgo de Noso Capital, lidera la ronda de inversión abierta por ADNTRO Genetics que asciende a 1 millón de euros, para impulsar la expansión de N-GE...
Inbergune ha decidido crear un fondo enfocado en biotecnología, dos años después de que el 60% de la empresa fuera adquirida por Moira Capital, dirigida por Javier Loizaga. Este nuevo fondo, llamad...
Fecundis, a medical technology start-up specialising in reproductive health, based at the Barcelona Science Park, has announced the successful closing of its seed funding round, securing $2.4 million ...
Sequentia Biotech, a #deeptech and leading bioinformatics company focused on the analysis and application of omics data, announces a €10million Series A, led by Seventure Partners, a French Venture ...
Tolerance Bio is developing an allogeneic, or “off the shelf,” thymus induced pluripotent stem cell (iPSC)-based cell therapy platform as well as pharmacological thymus therapies to address immune...
Esta cita, única en España, ha concentrado el foco de atención en torno a la inteligencia artificial (IA) aplicada a la salud debido al enorme potencial para revolucionar el diagnóstico, tratamien...
This 2023 has been a great year in terms of funding received by the public research institutes, centres and groups at the Barcelona Science Park, which mobilised 69.9 million euros, of which 57.1 mill...
Agomab Therapeutics has announced a $89 million Series D financing round, with participation from new investors Sanofi and Invus, as well as existing investors, including Asabys Partners.
The round was led by imec.xpand with new investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and Avançsa. Existing investors Asabys Partners, Aliath Bioventures and Vsquared also participated, bri...
HTBA is a science-based global leader in the manufacturing and commercialization of citrus flavonoids and active forms of vitamin B12 for the pharmaceutical, nutraceutical, food and beverage and a...
Biointaxis, an academic spin-off from the Germans Trias i Pujol Research Institute (IGTP) founded in 2018, is developing the first drug designed to prevent and reverse the neurological and cardiac eff...